/ | fl ! ik-19618023888view=pl&q, 7 7 aie in WHO's Ebola declaration and vaccine trials —_https:/mi | ° Cr it Jano Burgermeister Irregulari ies i in WHO's Ebola declaration and vaccine trials Jano Burgormeister 17 February 2015 at 19:46 To: wollestons@pariiament uk, teathers@pariiament.uk, James.Kelly. msp@scottish parliament.uk, CMOweb@dh.gsi.gov.uk, phso.enquiries@ombudsman org.uk, engiand.contactus@nhs.net, health@unison.co uk, executive. council@unitetheunion org scotland@unitetheunion.org, BMAScotiand@bma.org.uk, BMAWales@bma.org.uk, BMANorthernlreland@bma.org.uk, simon.danczuk.mp@parliament uk, siobhain.medonagh.mp@partiament.uk, thesecretary@toryclubs.co.uk, news@exaronews.net, new. scotland yard@met police uk, office@westminsterconservatives.co. uk, abbotd@parliament.uk, adamsg@parliament.uk, adamsn@parliament uk, affiyiea@parliament.uk, ainsworthb@parliament.uk, aidousp@parliament.uk alexanderd@parliament.uk, alexandera@parliament.uk, alir@parliament.uk, alleng@parliament.uk, amessd@pariiament uk, andersond@parliament.uk, andrews@parliament.uk, arbuthnotj@parliament uk, austini@parliament.uk, baconr@parliament uk, bagshawel@pariiament uk, balleya@parliament.uk, bainw@parliament.uk, bakern@parliament.uk, bakers@parliament.uk, baldryt@partiament.uk, ballse@pariiament uk, banksg@parliament.uk, barciays@parliament.uk, barkero@parliament.uk, barronj@parliament.uk, barwellg@parliament.uk, barclayh@parliament uk, bebbg@parliament uk, beckettm@parliament.uk, begga@parliament.uk, beitha@parliament uk, bells@parliament.uk, bellinghamh@parliament.uk, bennh@parliament.uk, bentonj@pariiament.uk, benyonr@parliament.uk, bercow|@parliament.uk, beresfordp@parliament.uk, berger|@parliament.uk, berryi@parliament.uk, bettsc@pariiament.uk, binghama@pariament uk, binleyb@parliament.uk, birtwhistleg@parliament.uk, biackmanb@pariiament.uk, blackman-woodsr@parliament.uk, blackwoodn@parliament uk, blearsh@parliament.uk, blenkinsopt@parliament.uk, blomfieldp@parliament.uk, blunkettd@parliament.uk, bluntc@parliament.uk, bolesn@pariiament.uk, bonep@pariiament.uk, bottomleyp@parliament uk, bradleyk@parliament.uk, bradshawo@parliament.uk, blaket@parliament.uk, braya@parliament uk, brazierj@parliament.uk, bridgena@parliament.uk, brines@parliament.uk, brockenshirej@parliament.uk, brookee@pariiament.uk, brownn@parliament uk, brownt@parliament. uk, browng@pariiament.uk, brownl@pariament uk, brownej@parliament.uk, brucem@parliament.uk, brucef@parliament uk, buckk@parliament.uk, bucklandr@pariiament.uk, burdenr@parliament.uk, burleye@pariiament. uk, burnhama@parliament.uk, burnss@parliament.uk, burnsc@parliament.uk, burrowsd@parliament.uk, burstowp@pariiament.uk, burtaa@parliament.uk, burti@partiament.uk, bylesd@parliament.uk, byrnel@parliament.uk, cablev@perliament uk, caimsd@parliament.uk, dakinn@parliament.uk, danczuks@parliament uk, darlinga@pariament uk, daveye@parliament uk, davida@parliament. uk, davidsona@parliament.uk, pikel@parliament.uk, daviesp@pariiament uk, glyndaviesS@btinternet.com, davidd@pariiament.uk, nick debois@parliament.uk, gloria@gloriagmp.org, denhamj@parliament. uk, dinenagec@parliament.uk, djanoglyj@pariiament uk, dobbinj@parliament uk, donsonf@pariiament uk, docherty’@parliament.uk, doddsn@parliament.uk, dohertyp@parrliament.uk, donaldsonjm@parliament.uk, donohoeb@pariiament uk, doranf@parliament.uk, dorrells@parliament.uk, dorriesn@parliament.uk, dowdj@parliament.uk, doyleg@parliament.uk, draxr@parliament.uk, dromeyj@parliament.uk, duddridgej@parliament uk, dugherm@parliament uk, duncana@parliament.uk, dunnep@parliament uk, durkanm@parliament uk, eaglem@parliamont.uk, eaglea@parliament.uk, edwardsj@pariiament.uk, effordc@partiament.uk, elloti@parliament.uk, ellism@parliament uk, ellsonj@parliament uk, ellmanm@parliament.uk, eliwoodt@parliament.uk, elphickec@parliament uk, engein@pariiament.uk, estersonb@parliament.uk, eustice3g@parliament.uk, evansc@parliament.uk, evansg@pariament uk, evansj@parliament.uk, evennettd@parliament uk, fabricantm@parliament.uk, falionm@pariiament.uk, farrellyp@parliament.uk, farront@parliament.uk, featherstonel@parliament uk, fieldf@pariiament uk, fieldm@parliament.uk, fitzpatrickj@parliament.uk, flellor@parliament uk flinte@pariament.uk, flynnp@parliament.uk, fosterd@parliament.uk, fovarguey@parliament.uk, foxl@parliament.uk, francish@parliament.uk, fullbrookl@parliament.uk, galer@pariiament.uk, gapesm@parliament.uk, gardiner>@parliament uk, gamiere@parliament.uk, garnierm@parliament.uk, gauked@pariament.uk, gobbn@pariiament.uk, gilberts@parliament uk, gildernew@parliament.uk, gillanc@parliament.uk, gilmores@parliament.uk, glassp@parliament.uk, glenj@parliament uk, glindonm@parliament.uk, godsifir@parliament uk, gogginsp@parliament.uk, goldsmithz@parliament.uk, ‘goodmanh@parliament.uk, goodwillr@parliament uk, granth@parliament uk, grayi@pariiament.uk, graylingc@parliament uk greatrixt@parliament.uk, greend@parliament uk, greenk@pariiament.uk, greeningj@parliament.uk, greenwoodl@parliament uk, gfieved@parliament.uk, grifthsn@parliament.uk, grifithse@pariiament.uk, gummerb@parliament.uk, gwynnea@parliament uk, gyimahs@parliament.uk, hainp@parliament.uk, halfonr@pariiament.uk, hamesd@parliament. uk, hancockm@parliament.uk, matthewhancock mp@pariiament uk, handsg@parliament.uk, hansond@parliament.uk, harperm@perliament.uk, harrist@parliament.uk, harrisr@parliament.uk, harts@parliament.uk, harveyn@parliament.uk, haselhursta@perliament.uk, havardd@partiament.uk, hayesd@parliament uk, healdj@parliament.uk, healeyj@pariiament uk, heathd@parliament.uk hemming|@parliament.uk, hendersong@pariiament.uk, hendrickm@parliament.uk, hendryc@parliament uk, hepburns@parliament uk, heyesd@parliament uk, hilingj@parliament.uk, hindsd@pariiament.uk, hodgem@parliament.uk, hodgsonm@parliament.uk, hoeyk@pariament.uk, hollingberryg@parliament.uk, hollobonep@parliament uk, hollowaya@parliament.uk, hoodj@parliament uk, hopkinsk@pariiament uk, kris hopkins@parliament.uk, horwoodm@parliament.uk, hosies@parliament.uk, hoylel@parliament.uk, hughess@parliament.uk, huntt@parliament.uk, 1of3 23/07/2015 13:28ongle.comnail/?ui-28k-a96 180238 view “PEG, Gait - Irregularities in WHO's Ebola declaration and vaceine trials httpsval hupperli@parliament.uk, huidn@partiament.uk,lisleye@parliement uk, irancadaviesh@parliament.uk jacksong@parliament.uk, jacksons@parliament.uk, sianjames@pariiament.uk, jamesm@pariament.uk jamiesonm@parliament.uk, javids@parliament uk, jenkinb@parliament.uk, jchnsona@partiament.uk, johnsond@parliament.uk johnsong@pacliament.uk, jonnsonj@parliament.uk, jonesh@parliament.uk. jonesk@patliament.uk, jonesd@parliament.uk joness@parliament uk, jonesg@parliament.uk, howellt@parliament.uk, joycee@parliament.uk, kawezynskid@pariiament.uk, keeleyb@paarliament uk, keena@parliament. uk, kelly@parlement.uk, khans@pariament uk, kirbys@parliament.uk, knightg@periament.uk, kwasi kwarteng mp@parliament uk, lainge@parliament.uk, lambn@periament uk, lammyd@parliament.uk, lancasterm@pariament.uk, laveryi@pariament. uk, lazarowicem@parliament.uk, leadsoma@pariiament.uk, leep@partiament.uk, leej@parliament uk, leech|@parliament uk, lefroyj@pariiament.uk, leighe@parliament uk, charlote leslie mp@parliament uk, chris leslie@pariament.uk, lewisj@parliament.uk lewisi@parliament uk, lewisb@pariiament uk, ddeli@pariament.uk, idingloné@pariament.uk, loyds@pariament.uk, ‘iwyde@parliament.uk, longn@parliament uk, lordj@parliament.uk, loughtont@parliament.uk, lucasl@parliament.uk, lucasc@parliament.uk, lumleyk@parliament.uk, macleodm@parliament uk, macnella@parliament.uk, macshaned@pariament uk, mactaggart{@parliament uk, mahmoodk@parliament.uk, mahmoods@parliament uk, maina@pariiament.uk, mannj@pariament.uk, marsdeng@parliament.uk, maynardp@parliement.uk, mocabes@parliament uk, mocarthyk@parliament.uk, mecartney@pariiament uk, mocarineyk@pariiament.uk, meclymontg@parliament uk, mecreaw@pariiament uk, medonaghs@pariiament uk, medonneli@pariament.uk, medonnella@parament uk, mefaddenp@parliament uk, megoveryj@parliament.uk, meguirea@parliament uk, mckechina@parliament.uk mckinnello@parliament.uk, mcioughinp@pariament.uk, mevete@parliament.uk, mealea@parliament.ck, meainsi@parliament.uk, menziesm@parliament.uk, metcalfs@parliament uk, michaela@partiament uk, millera@pariament.uk ‘millerm@pariiament.uk, milsn@pariiament.uk, mitona@parliament uk, mitchella@pariiament.uk, mordauntp@parliament.u mordenp@partiament.uk, morgann@parliament.uk, morriceg@parliament.uk, morrisg@parliament.uk, morrisj@parliament.uk morrisa@pariiament uk, morrisd@parliament uk, mosleys@parliament.uk, mowatd@pariament.uk, mudieg@parliament.uk, mulhollandg@periament.uk, mundelig@parliament.uk, munnm@pariiament.uk, murphyi@parliament.uk murphyc@perliament uk, murrays@parliament.uk, murrisona@perliament.uk, nandyl@parliament.uk, nashp@pariament.uk, nelly @partiament uk, newmarkb@parliament.uk, newtons@pariliament.uk, nokesc@pariiament.uk, normanj@pariiament.uk nuttalld@parliament uk, obriens@parliament uk, fiona.odonneli@parliament.uk, offorim@parliament uk, ollerenshawe@pariiament.uk, onwurahc@parliament uk, ottawayr@parliament uk, owena@parliament uk, parishn@parliament.uk, patelp@parlament.uk, pawseym@parliament.uk, pearcet@pariament uk, penrosej@parliament. uk, percya@parliament.uk, philipss@parliament.uk, philipsonb@parliament uk, picklese@parliament uk, pincherc@parliament. uk pounds@parliament.uk, primarolod@parliament uk, pritchardm@parliament uk, pugh|@parfiament.uk, qureshiy@parliament.uk, raabd@pariiament.uk, raynsfordn@pariiament uk, recklessin@parliament.uk, redwood @parliament uk, reedj@parliament.uk jacob reesmogg@parliament.uk, reevelis@pariiament.uk, reevesr@pariiament.uk, redida@pariiament uk, reynoldse@pariiament uk, teynalds|@pariiament uk, rifkindm@parliament.uk, riordanl@perliament uk, robathane@parliament.uk,ritchiem@parliament.uk, robertsonj@parliament.uk, robertsona@perliament uk, robinsong@pariament uk, rosindella@parliament uk, rotherams@parliament uk, royf@parliament.uk, royl@parilament.uk, ruanec@pariiament uk, rudda@parliement.uk, ruddocke@parliament.uk, rufleyd@pariament uk, russellb@parliament.uk, rutleyd@pariiament.uk. sandersa@parliament.uk, sendysi@parliament.uk, sarwara@parliament uk, scotti@pariament. uk seabecka@parliament uk, selousa@parliament uk, shannonj@pariiament uk, shappsg@pariiament.uk, sharmav@parliament uk, sharmaa@parliament uk, sheermanb@parliament uk, shelorookea@parliament.uk, shepherér@parliament uk, sheridanj@parliameni.uk, shukerg@parliament.uk, simmondsm@parliament.uk, simpsond@parliament uk, singhm@periiament.uk, skidmorec@parliament.uk, skinnerd@parliament.uk. skinnera@parliament.uk, smitha@parliament.uk, smithr@parliament.uk, smithe@parliament.uk, emithn@pariament.uk, smithh@pariiament.uk, smitho@pariament.uk, smithj@pariament uk, soamesn@pariament uk, soubrya@parliament. uk, soulsbyp@parliament.uk, spencerm@parliament uk, stanleyj@pariiament uk, stephensona@parliament. uk stewarth@parliamont.uk, stewarti@pariament.uk, stewart@parliament.uk, streeiers@parliament.uk, siridem@parliament.uk, stuartg@parliament.uk, stunella@parliament.uk, sturdyj@parliamentuk, sutciffeg@parliament.uk, swalesa@pariament.uk ‘swireh@parliament uk, thomasg@parliament.uk, thornberrye@parliament uk, thursoj@parliamen.uk, timsone@pariiament uk, tomiinsonj@pariiament uk, tredinnickd@parliament uk, trickott|@parliament.uk, tusse@parliament.uk, tuinera@parliament.uk, turnerk@partiament.uk, twiagd@parliament.uk, tyriea@parliament uk, varas@pariament.uk, vazk@parliament.uk, vickersm@pariament uk, walkerc@parliament uk, walkerr@parliament.uk, wqallaceb@parliament uk, walleyj@pariiament uk wardd@pariiamont.uk, watsont@pariament.uk, watted@parliament uk, weatherley@parlioment.uk, whiteforde@pariiament ik, whiteheada@perliament.uk, whittakerc@pariament.uk, wicksm@pariiament.uk, wigginb@parliament.uk, wiliamsh@pariiament uk, wiliamss@periament.uk, wiliamsonc@pariiament.uk, willamsong@parliament.uk wilsonr@pariiament.uk, winnickd@pariiament uk, wintertonr@parliament uk, woodcockj@parliament.uk woolasp@parliament.uk, wrightd@parliament uk, wrightj@pariiament uk, youngg@parliament uk Dear Dr Sarah Wollaston, Please find attached an Open Letter requesting an investigation by the House of Commons Health Committee into 2063 23/07/2015 13:28Gmail - Irregularities in WHO's Ebola declaration and vaccine trials butps:(/mail.yoogle.com/mail/ai-28 ik-396 1802388 view -pisy, inegularities indicating that fraud, abuse and corruption and mismanagement involving the World Health Organization (WHO) and GlaxoSmithKline (GSK) ocurred in WHO's declaration of Ebola as a Public Health Emergency of International Concern on 8th Augusi, 2014 Sincerely, Jane Burgermeister Bird£u666 wordpress blog 4 attachments formenty-1{1}.png am 443 Ebola_Vaccines_Opon_Letter pdf. pdf 382K _ Heer omail.oxps : 208K =} Hinausschrift BMG-92400_0049-.B 8.2009, 20.05.2009. Burgermster Jane(t) pat 4 55K Bors 202015 13:28[2] OPEN LETTER TO THE CHAIR OF THE COMMONS HE LTH COMMITTEE CALLING FOR AN INVESTIGATION INTO IRREGULARITIES # WHO'S EBOLA EMERGENCY DECLARATION # EBOLA VACCINE TRIALS IN THE CONTEXT OF THE MEDICAL INNOVATION BILL Dr Sarah Wollaston MP, Chair of the Commons Health Committee, House of Commons, London SWIA 0AA United Kingdom February 17, 2015 Dear Dr Sarah Wollaston, | am writing to you to request an investigation into irregularities indicating that fraud, abuse and corruption and mismanagement involving the World Health Organization (WHO) and GlaxoSmithKline (GSK) occurred in WHO's declaration of Ebola as a Public Health Emergency of International Concern on 8th August, 2014 . ‘The impact of the WHO declaration on the tax money, health and the human rights of the UK publie is far-reaching, Given the enormity -- yes, global impact -- of the declaration, it is regrettable that it hhas once more been made for the profit of pharmaceutical companies in a repeat of the swine flu seandal of 2009 as | show in this leter. | would like respectfully to invite you to view my wordpress blog, birdflu666, for more evidence and proofs. ‘The GSK Ebola vaccine is to be produced in large quantities - 230,000 doses in April - at about the same time as the Medical Innovation Bill is set fo become law. hutp://news.sciencemag.org/sites/default/files/Norway_submission WHO_EVD_230ct2014.pd¢ According to the FT, Johnson & Johnson has already manufactured enough Ebola drugs to treat more than 400,000 people with the potential for 2m courses by the end of the year. hitp://www.fi.com/ems/s/0/bd3 12dSa-9d92- | Le4-8946-00144feabde0 html#axz23PSUXhVDD The combination of a deregulated drug environment foreseen in the Medical Innovation Bill, experimental Ebola vaccine and drugs from GSK and other pharmaceutical companies as well as provisions for forced vaccination and quarantine allowed in the context of the International Health Regulations by a WHO emergency epidemic declaration, constitute an extraordinary and unprecedented threat fo the health and safety of the UK publ You may remember investigations into WHO's pandemic swine flu declaration in 2010, including, by the Council of Europe and BMJ, found that + the swine flu was a non event + the threat was exaggerated by WHO, pandemic criteria were lowered to allow for a declaration + “Key scientists advising the World Health Organization on planning for an influenza pandemic had done paid work for pharmaceutical firms that stood to gain from the guidance they were preparing. These conflicts of interest have never been publicly disclosed by WHO,and WHO has dismissed inquiries into its handling of the AMIN] pandemic as “conspiracy theories, hitp:/iwww-bmj.com/content/340/omj.c2912 + pharmaceutical companies made billions from the swine pandemic vaceine and drug contracts, + numerous adverse events, notably narcolepsy, have since been attributed by the UK government to ‘the swine fu vaceine par hupsfivww.telegraph.co.ukilifestyle/wellbeing/jamestefanu/10455755/Doctors-Diary-Swine-f- scientists-were-too-close-to-big-pharma him] utp:H/assembly.coe.int/CommitteeDocs/2010/20100604_H InIpandemie_E The Council of Europe inquity concluded the abuse of the swine flu declaration had led to a loss of trust among the publie, which “may prove disastrous in the case of the next disease of pandemic scope.” ive years later on, it i apparent none of the reforms promised in 2010 by WHO General Director Dr Margaret Chan in relationship to transpareney and accountability took place, 1 offer evidence that a scheme was put in place and executed by WHO officials to make false statements to induce the publie to accept an unnecessary deelaration to direct vac to GSK. WHO officials + exaggerated the Ebola threat + concealed vested interests in a declaration and masked that pharmaceut to make billions from Ebola vaceine and drug contracts al compan ‘s to pharmaceutical jemic + failed to disclose that scientists with personal and or companies sat on the key board advis + allowing trials which could involve up to 30,000 people in Liber atmosphere of intimidation + downplaying the risks of the trial, and s infect people with Ebola to go ahead in an self could ic literature suggesting the vaccine An unnecessary Ebola declaratioy | will deal, first of all, with the evidence proving that WHO officials knowingly and systema ed the threat of Ebola to create the impression that the outbreak was raging out of control to unnecessary, detrimental (0 tax money, the public health, exagg induce the public to accept a vaceine which and human rights, In declaring Ebola an public health emergeney in August, WHO discounted the assessment of its own Ebola expert, Dr Pierre Formenty, who was best informed about the outbreak. Ina pres s briefing in Geneva on June 27th ~ just five weeks before the declaration -- WHO media spokesperson Glenn Thomas introduced WHO's Ebola expert Dr Pierre Formenty. In response to aygtessive questioning from reporters and Doctors without Bonters, Dr Formenty eategorieally denied that Ebola was "out of control, He repeated this denial in the face of aggressive questioning. hup:/fwebty.un.org/topies-issues/specialized-agencies/watch/geneva-press-briefing- hre-ipu-wio-tmeee-wher ‘ohcht-unher-iom-wfp/364627907400 1 full-text AUN press release states: "Responding to @ question on whether the situation had “got out of hand” Dr. Formenty replied that the situation was not out of hand, and a lot of work had been done in the three affected countries - Guin Sierra Leone and Liberia ~1o tackle the situation and stop the transmission of Ebola virus," according to aUN press release. hup://wwwuinog.ch/80256EDDO06R9C2EM{htipNewsBy Year, en\/CEGSSE6FA389FOSC 125712040044 F 95 4?0penDocument Formenty's statement that Ebola was not out of control contradicted the assessment of NGOs and other entities "When Doctors Without Borders bevan warning in April that the outbreak was out of control, a dispute broke out between the NGO and a World H who insisted it was contained.” hutp://vww-haaretz.com/newshworld/1.6213 14 Thomas was declared dead in conferences to give a WHO postponed an emergency declaration until August when Gle the MH17 plane crash and no longer able to give Dr Formenty a platform at press factual assessment of the Ebola threat. points-lo-us-kie ccoveraup-oF- filed false- hitpsi/www-globalresearch.ca/mh 1 7-verdict-real-evides fag/5393317 A WHO chant showing Ebola cases in Guinea, Liberia and Sierra Leone show Ebola exses were falling on July 31°, 2014. This offers more proof Ebola was under control the week before the dectaration was made under false pretences. Please see altachmrent | (Formenty) In September, WHO affiliate, the U.S. Centers for Disease Control and Prevention (CDC) released a forecast claiming Ebola could potentially infect 1.4 million people in Liberia and Sierra Leone by the end of January, 2015 as part of the hype. hitp://www.nytimes.com/2014/09/24/health/ebola- estimates. himt?_1=0 In fact as of January 26th, 2015, only five confirmed Ebola e: containment of Ebola was achieved using standard epidemic control me contact tracing, and isolation, illustrating, firstly, that the tebola outbreak was under control as Dr Formenty stated, and secondly, that there is no need to deploy experimental vaccines to eradicate Ebola, hup:/fwwwtheguardian.com/vorldi20 1 5/jan/26rliberia-ebola-only-five-people-being-treated-for jpentagon/20 |5/02/04/military-cbola-mission-in-liberia wses-coulld-reach-|4-million-in-d-months-cle= ses were reported in ures such ats qua ‘omin hupfwwwmilitarytimes.comistory/military to-an-end/22888079/ New confirmed Ebola cases in Liberia, Sierra Leone and Gi were the lowest tally since June 2014, according to the WHO. nea totalled 99 in the week to ‘hola deca le for the be| would like to direct your attention to evidence that WHO officials conspired as early as April 2014, to conceal from the public that the F tion was made not beeause of a raging outbreak but for the benefit of pharmaceutical companies ola deelai Aware of the criticisms of the inquiries in 2010, and afraid of the disastrous collapse in trust predicted by the Council of Europe ifthe public became aware that GSK had a vested interest in an Ebola declaration, WHO officials hatched out a plan to misrepresent the truth to the public in order to avoid publi scrutiny and direct vaccine contracts to GSK, Merek and other pharmaceutical companies. ‘On Aprit 31d, | sent a query 0 WHO spokespersons Glen Thomas and Gregory Haertl in my capacity as a science journalist who has a blog, the bird 1u666 wordpress blog. asking whether there were any conflicts of interests which could influence WHO to declare Ebola an emergency, tert, In | would like to direct your attention to the reply of WHO s leading spokesperson I 7 email sent at 14; 59 on April 3 he stated that there was" ivirals available for ola." when there is no vaccine and no antivirals available for Ebola," he wrote. Please see attachment 2 for a copy of the email. ker for $325m, called lou, View In fact, in May 2013, GlaxoSmithKline (GSK) bought a Swiss vaceine- Okairos, which had a preclinical Ebola vaccine candidate. On 24 March 2014, Dr Ripley Ba President of GlaxoSmithK line (GSK) Biologicals, contacted WHO {o lask if they were interes vaceine, hup://vww.nebi.nlm.nih.gov/pme/articles/PMC4271692/ A WHO official speaking English, who appears to be Dr Marie Paule K: in be heard saying, in a German radio radio broadcast on 15 February 2015 “He sent me a message in March, and said you know we have this vaccine on the shelf. Are you interested ...thinking that this was way too late, hutp:fiwww.deutsehlandfunk.de/medizin-versuch-und-inrtumn-ebola-studien-im- cilverfihren.740.de.hum}?dramcartiele_id=3 10899)‘This shows that management at WHO received a timely arch 24 of the GSK vaccine, It is to be expected that WHO spokesperson Haertl, whose Depaertment of Communication directly subordinate to the Director General's Office in the organizational hierarehy, would have declared this potential conflict of interest when I asked! My query is significant because it was the one time media query appears (o have been directed to WHO concerning potential conflicts of interests, Also, Haertl, as the WHO Coordinator of News, Social Media and Monitoring, sent a copy of his email containing the false claim there was no Ebola vaceine to seven other media and communication officials in WHO. Concealing conflicts of interest appears to have been the official poliey adopted as carly as April 2014 | would respectfully like draw your attention to the growing importance of the alternative med asa soutce of information for the public today. | am an experienced seience journalist who has written for Nature, the BMJ, The Scientist, The Guardian and other publications as Google Scholar shows. hutps:l/scholar.google.com/scholar?hidedq=jane Hburgermeister&ebinG=et My birdMu666 wordpress blog has followed WHO and pandemies since 2009, Regrettably, the blog has catalogued a record of abuse. In brief, | started the bircf1u666 blog in 2009 reporting on a scandal involving the contam of 72 kilos of seasonal flu with the deadly bird flu in Baxter's biosecurity level 3 facilities in Orth an der Donaw , Baxter sent the deadly material to labs in four countries, nearly sparking a global bird fu pandemic. 1 would also like to draw your attention to a letter from the Austrian Ministry of Health confirming that the state prosecutor opened 3 stigation into the Baxter contamination incident afte I filed charges in April 2009. Please see attachment 3 (Hinausschrifi). Striet biosecurity level 3 procedures at the Orth an der Donau facilities make an accidental contamination virtually In addition, | would like to draw your attention to my subsequent coverage of the swine flu seandal and WHO s inyolvement on my blog and els incident and the dangers of the experimental swine flu vaccine received about 450,000 views. ewhere. For example, a YouTube clip in German on the Baxter hutps:www youtube.com/watch?v=5_RSEHN9OY The impact which alternative media can have on the public opinion is illustrated by the fact that only, for example, 3% of the Austrians and 6% of the Germans and Freneh took the swine flu vaeeine in 2009, This in spite of massive encouragement t0 do so from their governments and the mainstream media, F allege WHO officials resorted to a conspiracy to make false statements to my blog media precisely in order to avoid the intense publie serutiny, which WHO could expeet for its second emergency declaration in five years. If the public had been made aware through my blog and other alternative media that GSK had offered WHO its Ebola vaceine already in Mareh 2014, i would have ed (oa much greater serutiny of conflicts of interests ahead of the declaration, and may revented the declaration altogether given the many other irregularities, including the assessment by Dr Pormenty that there was no out of control Ebota epidemic - an assessment backed up by WHO charts, nd othe! | tum now to the second of piece of evidence that WHO adopted a policy of conspiring to make false statements to conceal conflicts. The head of WHO, Direetor General Dr Margaret Chan, grabbed hheadlines around the world in November 20 14 when she made the misleading statement that there was no Ebola vaceine there was "no incentive for drug companies to make something that won't be profitable.Inapstwwwsalon.com/2014/1 1/04/vho_dinector_condemns_profit_ driven, pharmaceutical industty, for ing_10_produce_ebola_cure/ lations/WHO-slams-pharma-for-failing-to-invest-in- http://www. biopharma-reporter.com/Markets-Re} non-profitable-Ebola-R-D bttp:/Aime.com/3555706/who-ebole vvaceine-pharr ‘aceutical-indusiry-margaret-chan? hup:ftime.com/3555706/who-ebola-vac ine-pharmaceutical-industry-ma Ebola emergency declaration advisor qualified them from participation in I contracts (0 phi jeual Furthermore, WHO failed to disclose that several of WHO have links to pharmaceuticual companies which should have di matters concerning an Ebola declaration which directs substant companies. For example, Sam Zaramba, who ists on the Mectizan Expert Committee sponsored by GSK and Merck and who has participated in meetings sponsored by GSK and Merek, among other links nbers_20140806/en/ butp:/twwwewho.int/ihe/proceduresfemer hup://www. mectizan.orglabout/mectizan-expert-committee Professor Lucifle Blumberg also has links to phramaceutical companies, including Novartis and Sanofi Pasteur hitp:/www.astim.org/defdowntoads/files/im20.pdr Intpsi/www.who.int/est/resources/publications/swinefw/h|nt_guidelines_ pharmaceutical mngl.pd? threat of arrest ‘The Ebola emergeney declaration gave pharmaceutical companies the advantage that it lowered standards for vaceine and drugs, and so gave GSK and other pharmaceutical companies + an instant market for a preclinical experimental Ebola vaceine A standard vaceine undergoes three elinical trials under the traditional approach and takes on average 10.71 years to develop, Also, a vaccine only has a 6% chance of entering the market. Drugs can lake 10 to 15 years to develop with 95% failure risk at point of discovery. The GSK Phola vaccine is one of the most rapidly fast-tracked vaccines in history with only four weeks of phase one elinieal trials on 60 people in the UK before a phase 3 trial planning to enrol! about 30,000 people started at the end of Januaryin Liberia nipsnews sciencemag ong/sites/defeullfiteyNorway_ submission WHO_EVD_230c(2014 pd + huge potential profits Dr. Anthony Rauci, Director of the U.S, National Institute for Allergy and Infectious Diseases, told The Canadian Press that i's “quite conceivable, if not likely” that fast-tracked Ebola vaccines may have (o given to entire countries hupshiwww.globalresearch.ca/u-s-national-i2: countries-to-stop-ebola-outbreak/5407196 lute-ofhealth may-have-(o-va A WHO business plan has the goal of developing enough pandemic vaceine to immunize the world’s population, hitp:apps.who. int/vaccine_researelvdocuments/Report%20McKinsey%20Business%20Plan%20F 13 ,pof + blank cheque to conduct trials on vast numbers of people circumventing con The PREVAIL vaceine trial does not appear to Follow WHO Standard Operating Procedures for conducting clinical vaccines trials, Altogether 19 representatives from the UK government and two from GSK were ‘meeting on financing the Ebola vaccines on January 8th, which overrode the decisions of a previous ‘meeting, the Joint Review of ChAd3 Ebola Vaccine Trials, on December 15", in whi scheduled to participate in the Ebola trial appear to have asked for more safely data before proceeding with clincial phase 2 tials in five countries other than the three affected by Ebola weed ina WHO Ih African countries inttps/vww.who.int/mediacentre/events/201 Siebola-vaccine-accessen! huip:ftwww who int/medicines/ebola-treatment/vaccines-meeting-lop.pal?ua=1 A WHO meeting report stated that preparations for concurrent Phase Hand Phase HI trials were already at an advanced stage,” that is to say, clinical phase 2 trials were seraped altogether “Preparations for concurrent Phase 1 trials in healthy volunteers outside the affected countries and Phase 111 trials in the affected countries are already af am advanced stage.” hetp:/fapps.who iaviris/bitstream/10665/149045/1/WHO_EVD, Meet MIS_15.1_eng.pdf?ua=1 hitpuAvww.who.int/medicines/ebola-treatment/meetings/gsk-vaceine-trials.pdf ‘The January 8" WHO meeting report states that eritical safety data were not available when the decision was made to go ahead with large-scale trials, “However, further data on the immune response elicited by each vaccine will need to be the coming weeks to inform dose selection for forthcoming efficacy trials, Results from a study by an Osford University group investigating the effects of a booster dose with an MVA-EBO vaccine after priming with the Chad3-ZEBOV vaccine suggest that immune responses were up to a 10-fold higher 2 weeks after boosting, Further results will be available soon. Critical decisions about the next phase of clinical development will be made for both vaccines very soon, once the totality of safety and immunogenicity data are available, ~ states the WHO report on the January 8th meeting. lysed in uup:/fapps.who inviisfbitstream/10665/149045/1WHO_EVD_Meet_MIS_15.1_eng.pdfua=1 a gover! + the capacity (0 suspend freedom of speceh, freeciom of the pre Deputy Minister for Public Affairs at the Ministry of Information, Isaac Jackson, appearing at the side of the WHO scientist in charge of the trials, Dr Stephen Kennedy, threatened to arrest any journalist, lawy: nent official who expressed criticism or legitim: Ebola expereimental vaceine trials on Febreary 10th, 2015, fe concerns about the of gover hittp:vww-inprofiledaly.com/2qarticle/108-take-tial-vaccines-42-side-eflvets-reported butt6E2%80%A6 +a blank cheque to circumvent political controlsOn February 3", Liberian parliament assumed its responsibilities imposed upon it as representatives of the people attempted to ascertain the facts behind this tial eonducted in a veil of secreey. Tt “mandated of (wo separate Ebola vaceines rian people through the Legistatare.” several of its committees to investigate why decision on the t Liberia hay not been adequately explained to hitpufallafrica.com/stories/201502050985. hum! an Deputy Mi ion will proceed. ‘One Week after the announcement, the threat of arrest was issued by the Lib for Public Affairs at the Ministry of Information and i investig is not clear if th ws 0 the ine trials are often illiterate, the poor, people without 1 isks. Nor should they. It is the obligation of the The vietims of these vac internet, They cannot inform themselves of the authorities to inform people of the risks of this unprecedented experiment. ise death and sickness +a blank cheque to Libetians are, and should be concerned about the incredible plan to give £0 30,000 people a vaccine ich there is no proof that itis safe or effective. On the contrary, what documentation there is indicates the GSK vaccine could even infect people with Ebola. Developed with NIH, the GSK Ebola “Chad? vaccine is made from a combination of an Ebola virus and a cold virus, a chimp adenovirus {ype 3 (ChAd3). An HIV vaccine, which used the same cold virus as the GSK Ebola vaccine, was halted because it was found to give people HIV. Men who had previously caught colds caused by the “cold” virus used to make the HIV vaccine were two (0 four times as likely fo become infected with HIV if they got the HIV vaccine. The Step trial of the NIATD and Merck HIV vaccine was halted in phase 1b in 2007 when results showed that people were being infeeted by the vaccine, but the GSK vaceine trial will not undergo the same clinical trials hitp:i/www.nytimes.com/2012/05/18/health/research/rial-vaccine- study-confirms.html hitp:/!www.nim.nih. govidatabases/alerts/hiv_step_study..ntml The GSK vaccine is based on data obtained from trials in monkeys, which did not show lasting protection, Six of the eight macaques monkeys who were given one Ebola “ChAd3” shot died at months, |itps//www.reuters,convarticte/201 4/09/07/us-health-ebola-vaccines-idlJSKBNOH20NQ20140907 for wi acde-some-more-vulnerable-t0-hiv- Also, the monkey trial involved a mild lab form of Ebola and not the harsh west Africa type so itis hard to extrapolate the data. Apart from the animal trial, the GSK vaccine has only undergone a four week clinical phase | trial on 60 healthy adults in the UK, which reported few adverse events. “Fever developed in 2 of the 59 participants who were evaluated. Prolonged activated partial- thromboplastin times and transient hyperbilirubinemia were observed in 4 and 8 participants, respectively.” http://www nejm.org/doi/pdt/10.1056/NE.JMoa 1411627 By contrast, the PREVAIL trial has reported 42 adverse events on the fi alone, http:/Avww.inprofiledaily.com/?q=article/108-take- but%E2%80%A6 Prior (0 2014 all Ebola vaccine trials were discontinued. The three most re trials were suspended, terminated or withdrawn in phase I of clinical trails. hupitinews.sciencemag.org/sites/defaulefiles/Norway:_ submission, WHO_EVD, 230c2014.pdt inl-vaceines-42-side-effeets-reported- f Ebola vac In brief, the GSK experimental vaccine could never be given to so many people if WHO had not lowered the bar to allow even dangerous vaccines to be given to people.The slightest risk that the vaceine could give someone Ebola should be enough to stop the trials mmediately. To infect someone with Ebola, a deadly disease, which might kill them is an act of murder, torture and an atrocity. It he on thirty thousand people. There are plans to have & control group scrapped if Ebola surges as it may well do if people are infected by the vaccine, nothing to do with medicine. However, the Liberian trial could be conducted Questions have also been asked why PREVAIL, the administrators of the vaceine trial, are giving pauticipants two shots of a syringe or two doses at once ona single volunteer. It is not elear how safe the ola Virus in the vac en the problem of cold chain supply, quality control and contamination as the Baxter bird flu case shows. +a blank cheek to evade accountability Ifthe experimental subjects are infected with Ebola as a result of the GSK vaccine and ifsome of tee that this will whom died as a result, and others were caused great pain and suffering. there is no be recorded in the clinical results. Infection duc to the vaceine can be falsely attributed to di contact with Ebola patients in the chaotic conditions prevailing in Liberia allowing GS denial. tion fo court documents in Italy which reveal that GSK ays of receiving a G: I would also like to draw your at masked the death of 67 infants within ten itpy/swww.naturalnews.com/048430_vaceines, sudden. death Also, according to a study, eolleeting data on vaccines during an epidemic may be “impossible”. data obtained to assess benefit or toxicity could have innumerable biases and tions, making their application under current research standards impossible.” Also, misapprop? bhtp:/fannals.org/anicte-aspx°articleid= 1915876 +. shield against compensation claims in the event of dangerous side effects It emerged during a hearing in the Liberian Parliament at the beginning of February that it participants in the trial are infected with Ebola, or die from the vaccine, if they suffer an agonizing illness or death, there will be no compensation for them, PREVAIL. trial leader Dr Stephen Kennedy said there would be no financial compensation for people but negotiations with the Liberian Ministry of Justice were underway on the legal aspect. Even if money could redress the terrible sickness that could be visited on people from a defective Ebola vaccine, the coffers of the Liberian government seem (0 be empty. What will happen if thousands suffer long term effects from GSK vaccines in Liberia and other poor African countries? Who will compensate them? bup://www.firstwordpharma.com/node/I 26260: siLKWI sid=334anzz38 hulp: www heritageliberia.nevheritagenews/index.php/2014-07-17-17-09-3 /itenv930-ebola-vaceines-trial- back ires-as-lawmakers-launch-investigation n GSK s | would like to draw your attention to the fact that people who suffered damage flu vaccine are also seeking compensation from the UK government. Participants in the Liberian Ebola trials reeeive S410USD in exploitation of their dire poverty. IL is not clear if they receive compensation for follow up visits or if there are any follow up visits planned to monitor side effects. + the eapacity to deploy the military and violate human rights in the context of theInternational Health Regulations Liberia, for example, declared a state ofemergeney in early August, with a9 pm. eurfew and soldiers and police officers patrolling the streets. Communities we ed including a part of the Liberian capital called West Point, home {0 about 75,000 people. Ba residents without food and water, ‘The military fired on residents, killin wounding a 22-year-old man. was used fo lock in the -year-old boy and severely | would also like to draw your altention fo much more sinsister aspect running like a red thread though these researches. Dr. Francis Boyle, a scholar of bio warfare and international nw at the University of Hlinois, who drafted the jeal Weapons Anti sm Act of 1989, the US implementing legislation for the 1972 Biological Weapons Conyention, has said that Ebola originated in a. US bio weapons lab, “This isn’t normal Eboke at all.” boen genetically modified.” Boyle points to the existenee of US government laboratories in Attica th ating bio weapons under the guise of working on cures. In addition, Boyle says the speed of Ebola’s spread and the humber it is killing is proof that Ebola is a modified form, hutpu/www.informationclearinghouse.infofarticle40012.him itp://www.informationclearinghouse. in fofartieles0013.h he said. “I believe fttpu/Avww.waronwethepeople.com/another-cbola-problem-sol ed-natural-source-found/ httpv/www.globaltesearch,ca/ebola-genetically-modified-organism-developed-in-us-biowarfare laboratories-in-africa/5409003 hutps/www.washingtonsblog.com/2014/10/ebota-2.himl httpv/ivww.washingtonsblog.com/2014/10/bioweapons-expert-reaffirms-belief-ebola-es: lab.htmt ped-biowarfare- US bioweapons scientists working for Army Medical Research Institute of Infectious Diseases helped Okairos, a Swiss-ttalian biotechnology company acquired by GSK in 2013, develop the GSK Ebola vaccine. http://www.niaid.nih.gov/news/QA/Pages/EbolaVaxQA.aspx Ebola is one of the prieneiplalidseases which is researched by the US military, whieh raises questions about why the UK government believes ISIS could ever use it WHO made false statements about confliets of interests, systematically exaggerated the thr of Ebola and abused an Ebola declaration for the profit of pharmaceutical companies recalling the swine flu declaration scandal in 2009. WHO and GSK appear to have calculated that the gigantic potential gains from a fraudulent Ebola declaration outweighed the possibility of being held to account, Confident that weak internal controls, weak external oversight and a weak mainstream media would allow irrezulatities to go undetected, they advanced to what may be violations of eriminal laws on fraud. Knowing the GSK Pbola vaceine is not safe and anticipating damage, GSK and WHO chose victims from one of the world's most impoverished countries for a highly isregular trial, In the face of the justified concerns, the Liberian government has threatened to arrest journalists, lawyers and government officials who investigate the trial and its conduct. Ihe trials are supposed to be justified by the Ebola ontbi drug in Liberia brineidofovir was cancelled on February 3° be country are now so low that itis unlikely to get a clear result, How, ther Ebola smbers in thi i. Yet, a trial of a potenti se the F ola ease can the GSK vaccine wials bejustified? hup:\vww.theguardian.com/world/2015/feb/03/ebola-drug,-trial-liberia-halted ‘The value of the trials, conducted in the chaotic conditions of Liberia and in an atmosphere of terror and intimidation, will be worthless. Yet, if GSK Ebola vaccine is approved, it could be given to millions of people all around the world, incuding in the UK, and in a short time. rhe UK public will expect MPs to be proactive in investigating and referring to the appropriate investigative organizations evidence of potential fraud or corruption. A proactive investigation is needed to reassure the public that the white wash inquiries after WHO s unnecessary swine flu declaration in 2009 will not be repeated. Lask in particular for the role of Dame Sally Davies in the Ebola declaration to be put under serutiny. Due to her double role as the UK Chief Medical Officer and a member of the WHO Executive Board, Dame Sally Davies is in a unique position to coordinate the activities of WHO, the UK public health bodies and pharmaceutical companies. Atthe very least Dame Sally Davies must be held responsible for the lack of management control and oversight that allowed WHO (o make an Ebola emergency declaration fraudulently for the direct benefit of pharmaceutical companies for the second time in five years in spite of pledges by WHO to reform. Also, it must be asked why she has chosen to implement lax quarantine and screening policies in the UK when the NHS is ill prepared to handle Ebola eases and when these lax policies delayed the diagnosis of Scottish nurse Pauline Cafferkey when she arrived at Heathrow and asked to be tested seven times. I would like to direct your attention to the fact that the governors of the states of New Jersey, Connecticut and New York all introduced mandatory quarantine and tougher airport screening measures in October. The US army also introduced mandatory quarantines for its soldiers serving in Liberia. I-ebola-debate-14 14192508 hitp/Awww.wsj.com/articles/new-york-new-jersey-quarantines-f hupy/www.theguardian,com/us-news/20 1 4/ocV/29/us-troops-ebola-face-2 -day-quarantine-low-risk In January, New York Governor Andrew Cuomo announced financial support and other protections for returning Ebola health workers for their 21 day quarantine in a move designed to encourage personnel to continue to treat Ebola patients in West A rica. hutp:/farticle.wn.com/view/2015/01/20/Ebola_Aid_Workers_Said_to Get_Protections_in Cuomo_s NY_Bu dg Furthermore, I ask for investigation into whether the UK government has plans to follow the policy of the Liberian government and threaten to arrest lawyers, journalists or government officials Who express legitimate concerns about the GSK and other Ebola vaccines, should these vaccines ever be deployed for use in the UK. In particular, I also ask for clarification if there are any plans to use the new Facebook warriors belonging to the British army 77" Brigade, operative from April, in any. pyschological operations to intimidate, harrass people who express legitimate concerns about the safety and effectiveness of Ebola vaccines on the social me http://www theguardian.com/uk-news/201 5/janv/3 l/british-army-facebook-warriors-77th-brigadeI would also like to point to the strange death of WHO spokesperson jomas allegedly in the MH17 plane crash in the Ukraine on July 17th. You may recall Glenn Thomas gave a platform to the WHO Ebola expert Pierre Formenty who stated there was no need for an Ebola declaration as late as June 27", Glenn Thomas s death removed a key obstacle to the WHO declaration on August 8th.Relatives of the crash vietims have called the investigation into the MH17 erash a cover up. http: rf.com/news/212895-mh17-dutch-reject-un/ Given the huge amounts of money involved in the Ebola declaration In view of the catalogue of abuse of the International Health Regulations ~ the Baxter bird flu contamination scandal, the swine flu scandal and the Ebola declaration driven by commercial imperatives in just five years, I eall for these regulations to be abolished. I also call for proposals to inerease the powers of WHO in the event of a future epidemic declaration to be blocked. Information relating to irregularities in WHO's Ebola declaration and vaccine trials has been circulating around the globe in a number of languages for many months. I believe the disastrous collapse in public trust predicted by the Council of Europe in 2010 in the event of another abuse of a publie health declaration has already occurred and if the GSK Ebola vaccine is pushed on the people of the UK or Europe, the consequences could be unpredictable. Finally, I would Tike respectfully to invite you to view a copy of this letier on my wordpress blog, birdflu666, together with other evidence and proofs. Please note WHO has recently reorganized its website, and some of the links for WHO documents may have changed or disappeared altogether. Ifyou would like more information, please do not hesitate to contact me. ‘Thank you for your attention Yours sincerely, Jane Burgermeister6180238 view-pide, fer the Medical Innovation... hitps:/mail.google.com/mail/?ui-2eik Git - Ebgla vaccines can be given un Jane Burgermeister Ebola vaccines can be given under the Medical Innovation Bill without approval 100 messages Jane Burgermeister 24 February 2015 at 14:31 To: wollastons@pariiament.uk, teathers@parliament uk, James Kelly. msp@scoltish parliament.uk, CMOweb@dh.gsi gov.uk, phso.enquiries@omoudsman.org uk, england. contactus@nhs.net, health@unison.co uk, executive. council@unitetheunion.org, scotland@unitetheunion.org, BMAScotland@bma org.uk, BMAWales@bma.org.uk, BMANorthernlreland@bma.org.uk, simon. danczuk.mp@parliament.uk, siobhain.medonagh.mp@parliament.uk, thesecretary@toryclubs.co uk. news@exaronews.net, new. scotland yard@met police uk, office@westminsterconservatives.co. uk, abbotd@parliament.uk, adamsg@parliament.uk, adamsn@parliament uk, afryica@parliament.uk, ainsworthb@parliament.uk, aldousp@parliament.uk, alexanderd@parliament.uk, alexandera@parliament.uk, alit@parliament.uk, alleng@parliament.uk, amessd@parliament uk, andersond@pariament.uk, andrews@parliament.uk, arbuthnotj@parliament.uk, austini@parliament.uk, baconr@pariiament uk, bagshawel@parliament.uk, baileya@pariiament.uk, bainw@parliament.uk, bakem@parliament.uk, bakers@patliament.uk, baldryt@parliament.uk, EdBallsMP , banksg@parliament.uk, barclays@pariiament. uk barkera@parliament. uk, barronj@parliamant uk, banwelig@parliament.uk, barclayh@pariiament uk, bebbg@oarliament.uk, becketim@parliament.uk, begga@parliament.uk, beitha@perliament.uk, bells@parliament.uk, bellnghamh@parliament.uk bennh@parliament.uk, bentonj@pariament uk, benyon@parliament.uk, bercow;@parliament.uk, beresfordp@parlament uk, berger@parliament.uk, berryj@parliament uk, Clive Betts , binghama@parliament.uk, binleyb@parliament.uk, birtwhistleg@parliament.uk, blackmanb@parliament.uk, blackman-wooder@parliament.uk, blackwoodn@parliament.uk, blearsh@parliament.uk, blenkinsopt@parliament.uk, blomfieldp@parliament uk, Ri Hon David Blunkett MP , blunte@partiament uk, bolesn@parliament uk, bonep@parliament uk, Peter Bottomley , bradleyk@parliament.uk, bradshawb@parliament.uk, blaket@parliament.uk breya@parliament.uk, brazierj@parliament.uk, bridgena@parliament.uk, brines@parliament.uk, brockenshire|@parliament.uk, brookea@partiament.uk, brownn@parliament.uk, brownr@parliament.uk, browng@parliament.uk, brownl@partiament. uk brownej@parliament.uk, brucem@pariiament.uk, brucef@pariiament.uk, Karen Buck , bucklandr@parliament uk, Richard Burden , burleya@pariiament.uk, burnhama@parliament uk, burnss@pariiament.uk, burnsc@parliament.uk, burrowsd@pariiament uk, burstowp@pariiament uk, burtaa@pariiament.uk, burti@pariiament.uk, bylesd@partiament.uk, Liam Byrne , cablev@parliament.uk, caimsd@parliament.uk, dakinn@parliament.uk, danczuks@parliament.uk, darlinga@pariament.uk, daveye@parliament.uk, davidw@parliament.uk, davidsona@parliament uk, pikel@parliament.uk, daviesp@parliament uk, glyndavies&@otinternet com, davidd@parliament.uk, nick.debois@pariiament.uk, gloria@gloriadmp org, denhamj@parliament.uk, dinenagec@parliament.uk, djanoglyi@parliament.uk, dobbinj@parliament.uk, donsonf@pariiament.uk, docherty’@parliament.uk, doddsn@pariiament.uk dohertyp@parrliament.uk, donaldsonjm@pariiament uk, Brian Donohoe , doranf@pariiament.uk, dorrelis@parliament.uk, dorriesn@pariiament uk, dowdj@parliament.uk, doyleg@parliament.uk, draxr@parliament.uk, dromey|@periiament.uk, duddridge|@pariiament.uk, dugherm@pariiament.uk, duncana@parliament.uk, dunnep@parliament uk, durkanm@parliament uk, eaglem@parliament.uk, eagiea@pariament uk, edwardsj@parliament uk, effordc@pariiament.uk, eltictj@parliament.uk, ellism@parliament.uk, ellisonj@parliament uk, ellmanm@parliament.uk, eliwoodt@parliament.uk, elphickec@parliament uk, engeln@perliament.uk, estersonb@pariiament.uk, eustice3g@parliament.uk, evansc@parliament.uk, evansg@parliament uk, evans|@parliament uk, David Evennett , Michael Fabricant , falionm@parliament.uk, farrellyp@parliamont.uk, farront@parliament.uk, Lynne Featherstone , Frank Field fielim@parliament.uk, fitzpatricki@pariiament.uk, flellor@parliament.uk, fintc@parliament.uk, flynnp@parliament.uk, fosterd@parliament uk, fovarguey@pariiament. uk, foxi@parliament.uk, francish@parliament.uk, fullbrooki@parliament.uk, galer@parliament.uk, Mike Gapes Greatrixt@parliament.uk, hegell! , greenk@pariiament.uk, greeningi@pariiament.uk, greenwoodl@partiament uk, grieved@parliament uk, grifithsn@pariament.uk, grifithsa@parliament.uk, ‘gummerb@parliament.uk, gwynnea@parliament.uk, gyimahs@pariiament.uk, hainp@parliament.uk, halfonr@parliament.uk, hamesd@parliament.uk, hancockm@partiament uk, matthewhancock mp@parliament.uk, handsg@perliament.uk hansond@parliament.uk, harperm@parliament.uk, harrist@parliament.uk, harrisr@pariiament uk, harts@parliament.uk, harveyn@parliament uk, haselhursta@parliament.uk, havardd@parliament uk, hayesd@parliament uk, healdj@parliament uk, healeyj@parliament uk, heathd@parliament.uk, hemmingj@parliament.uk, hendersong@pariiament uk, hendrickm@parliament.uk, hendryc@parliament.uk, hepbums@parliament.uk, heyesd@partiement.uk, hillingj@pariiament.uk of 104 23/07/2015 13:22Ginail - Ebola vaccines can be given under the Medical hmovation ..._hlpsi/mail,google.conv/mail/?ui-28ik 961802388 hindsd@parliament.uk, hodgem@parliament.uk, hodgsonm@parliament.uk, hoeyk@parliament uk, hollingberrya@parliament uk, hollobonep@partiament uk, hollowaya@parliament.uk. hoodj@parliament.uk, hopkinsk@parliament.uk, kris.hopkins@pariiament.uk, horwoodm@partiament.uk, hosies@parliamont.uk, hoylel@pariiament uk, hughess@parliament.uk, huntt@parliament.uk, hupperti@parliament.uk, hurdn@parliament.uk, ilsleye@parliament uk, irancadaviesh@parlament uk, Glenda Jackson MP jacksons@pariament.uk, sianjames@pariiament uk, jamesm@parliament uk, jamiesonm@parliament.uk javids@pariiament uk, jenkinb@parliament.uk, johnsona@parliament.uk, jonnsond@parliament.uk, johnsong@pariament.uk, johnsonj@parliament.uk, jonesh@partiament.uk, jonesk@parliament uk, jonesd@pariiament uk, joness@parliament.uk, Jonesg@parliament uk, howellt@parliament uk, joycee@pariiament uk, kawczynskid@parliament.uk, keeleyb@paarliament.uk, keena@parliament.uk, kellye@parliament.uk, khans@parliament.uk, kirbys@parliament.uk, knightg@parliament.uk, kwasi.kwarteng,mp@pariiament.uk, lainge@parliament uk, fambn@parliament.uk, lammyd@parliament.uk, lancasterm@parliament uk, laveryi@pariiament.uk, iszarowiczm@parliament.uk, leadsoma@pariiament uk, leep@parliament uk, leej@partiament uk, leechj@parliamont.uk, lefroyi@perliament.uk, lsighe@parliament uk, Charlotte Leslie MP , chris leslie@parliament.uk, lewisj@parliament.uk. lewisi@parliement.uk, lewisb@parliament uk, liddelli@parliament uk, lidingtond@pariiament.uk, lloyds@parliament.uk, Iwyde@parliament.uk, longn@patliament.uk, lordj@pariament uk, loughtont@parliament uk, lucast@parliament.uk, (ucasc@parliament.uk, lumleyk@parliament.uk, macleodm@pariament.uk, macneila@parliament.uk, macshaned@pariament.uk, ‘mactaggartf@parliament.uk, mahmoodk@parliament.uk, mahmoods@parliament.uk, maina@pariament.uk ‘mannj@pariament.uk, marsdeng@parliament uk, maynardp@parliament uk, mocabes@parliament uk, mecarthyk@parliament.uk, mccartney@pariiament.uk, mccarineyk@pariiament uk, moclymontg@parliament. uk, mocreaw@pariament.uk, medonaghs@parliament.uk, John McDonnell MP ‘medonnella@parliament.uk, mefaddenp@pariiament.uk, megoveryj@parliament uk, meguirea@parliament.uk, mekechina@parliament.uk, mckinnetle@parliament.uk, mcloughlinp@parliament uk, mevete@parliament.uk, mnealea@pariament uk, mearnsi@parliament.uk, menziesm@parliament uk, metcalfs@parliament. uk michaele@partiament uk, millara@parliament.uk, millerm@parliament uk, milisn@parliament.uk, miltona@parliament.uk, mitchella@parliament.uk, mordauntp@parliament uk, mordenp@pariiament uk, morgann@parliament.uk. morriceg@parliament.uk, morrisg@parliament uk, morsis\@pariiament.uk, morrisa@parliament.uk, morrisd@parliament.uk, mosleys@parliament.uk, mowatd@parliament uk, mudieg@parliament.uk, mulhollandg@parliament.uk, mundellg@pariiament.uk, munnm@pariament uk, murphyj@parliament.uk, murphyc@patliament.uk, murrays@parliament.uk, murrisona@parliament.uk, nandyi@parliament.uk, nashp@partiament uk, neillb@parliament.uk, newmarkb@parliament.uk, newtons@parliament.uk, nokesc@parliament.uk, normanj@pariiament uk, nuttalld@pariiament.uk, obriens@parliament.uk, fiona.odonnell@parliament.uk, offordm@pariiament uk, ollerenshawe@pariament.uk, onwurahc@pariiament uk, ottawayr@pariiament.uk, owena@partiament uk, parishn@pariiament.uk, patelp@parliament.uk, pawseym@parliament uk pearcet@parliament.uk, penrosej@parliament.uk, percya@pariiament.uk, philipss@partiament.uk, philipsonb@parliament uk piokiese@partiament.uk, pincherc@parliament uk, pounds@pariiament uk, primarolod@patliament.uk, pritchardm@parliament.uk, pughj@parliament uk, qureshiy@parfiament uk, raabd@parilament uk, raynsfordn@parliament uk reckiessm@parliament uk, redwoodj@parliament.uk, reedj@parliament uk, jacob.reesmogg@parliament.uk, reevelis@pariiament.uk, reevesr@pariiament.uk, redida@parliament uk, reynoldse@parliament.uk, teynolds|@parliament.uk, rifkindm@parliament uk, riordani@parliament uk, cobathana@pariament.uk. ritchiem@parliament uk robertsonj@partiament.uk, robertsona@parliament uk, robinsong@parliament.uk, rosindella@pariiament.uk, rotherams@parliament uk, royf@parliament.uk, royl@partiament.uk, ruanec@parliament.uk, rudda@pariiament.uk, ruddocka@pariiament uk, ruffleyd@pariiament uk, russellb@parliament.uk, rutleyd@parliament.uk. sandersa@parlament uk, sandysi@partiament.uk, sarwara@pariiament uk, scotti@parliament uk, seabecka@parliament.uk, selousa@parliament.uk, shannonj@periiament.uk, shappsg@parliament uk, sharmav@parliament uk, sharmaa@parliament.uk sheermanb@parliament uk, shelbrookea@parliament.uk, shepherdr@pariiament.uk, sheridanj@parliament.uk, shukerg@parliament uk, simmondsm@parliament.uk, simpsond@parliament.uk, singhm@parliament.uk, skidmoree@parliament.uk, skinnerd@parliament.uk, skinnera@parliament uk, smitha@parliement.uk, smithr@parlament.uk smithe@pariiament.uk, smithn@parliament.uk, smithh@parliament uk, smitho@parliament.uk, smithj@pariament uk soamesn@parliament.uk, soubrya@parfiament uk, soulsbyp@parliament.uk, spencerm@parliament. uk, stanleyj@parliament.uk, stephensona@parliamont.uk, stewarlb@pariament uk, stewarti@parliament uk stewartr@pariiament.uk, streetera@pariiament.uk, stridem@parliament uk, stuarig@parliament.uk, stunella@parliament.uk, sturdyj@parliament.uk, sutclifeg@pariiament uk, swalesa@parliament.uk, swireh@parliament.uk, thomasg@parliament.uk thomberrye@parliament.uk, thursoj@parliament.uk, timsone@parliament.uk, tomlinsonj@parliament.uk, tredinnickd@parliament.uk, trickettj@perliament uk. trusse@parliament uk, tumera@parliament uk, tumerk@parliament uk, twigad@pariiament.uk, tyriea@parliament uk, varas@parliament uk, vazk@parliament uk, vickersm@parliament. uk, walkero@parliament.uk, walker¢@partiamont.uk, woallaceb@parliament.uk, Joan Walley , wardd@parliament uk, wattsd@parliament.uk, weatherley@pariiament.uk, whiteforde@parliament uk. whiteheada@parliament uk, whittakerc@pariiament uk, wigginb@partiament uk, wiliamsh@parliament.uk, willarnss@parliament.uk, wiliamsong@pariiament.uk, wilsonr@parliament.uk, winnickd@parliament.uk, wintertonr@parliament.uk, woodcock@pariament.uk, woolasp@parliament.uk, wright¢@pariiament.uk, wrightj@parliament.uk, youngg@parliament.uk, andrew clayton@penningtons.co.uk, swhite@leighday.co.uk, jose. miola@le.ac.uk 2of 04 23/07/2018 13:22Gmail - Ebola vaccines can be given under the Medical Innovation ...___htpst!/mail.google.com/mail/2ui’-28ik-1961 802388 view pg, Dear Dr Sarah Wollaston, In an Open Letter sent you a week ago, | asked you to investigate irregularites in Ebola vaccines and trials. | expressed my concern these potentially dangerus drugs could be given to the UK population without the approval of any regulatory authority f the Medical Innovation Bill becomes law. I you have had the opportunity to read the evidence | presented in my Open Letter, you will see why there is good reason to believe the GSK and other Ebola vaccines will likely never get approval even under emergency use provisions. Nevertheless, these same experimental vaccines can be given to the public if the bar is lowered to the point where any drug, no matter how dangerous, can be administered, and if every right to recourse and compensation for damage has been removed from victims. The lowering of the bar to create just such an environment is what the Medical Innovation Bill achieves. That is why I urge MPS to reject the Bill at its second reading on Friday, 27th February. https: www.opendemocracy.net/ourkingdom/david-hills-jos%C3%A9-miola/seatehi-bill-s-internally-inconsistent-and must-be-serulinised-in | ask you to consider the urgency of an investigation into irregularities in WHO's Ebola declaration and vaccine trials given the announcment by WHO today that pharmaceutical companies are ramping up their production, meaning millions of doses could be availabie later this year. ‘A group of so called experts, whose ties to pharmaceutical companies may or may not be disclosed, could consider vaccinating entire populations, according to Helen Rees af the University of Witwatersrand, who chaired the WHO meating hitp:iwiww.baxtorbulletin.comisioryfiferhealth/2015/02/2S)teading-ebola-vaccines-appear-sate-says/23001829/ Please note only about 320 people in Liberia have taken the Ebola vaccine so fer, according to local media. Also, local reports must be read against the background of a threat by the Liberian government to arrest journalists, lawyers and government officials who question the trial as you wil sae in my Open Letter and on my birdflu68 wordpress blog or from the original Liberian reports btlp:fattafrica.comistories/201502240949. htm ask you and all MPs to reject the Medical Innovation Bill on Friday as a first step towards halting a situation where a potentially very dangerous Ebola vaccine can be given to the UK public. ‘Yours sincerely, Jane Buergermeister On 17 February 2015 at 21:46, Jane Burgermeister wrote: Dear Dr Sarah Wollaston, Please find attached an Open Leiter requesting an investigation by the House of Commons Health Committee into inegularities indicating that fraud. abuse and corruption and mismanagement involving the World Health Organization (WHO) and GlaxoSmithKline (GSK) oceurred in WHO's declaration of Ebola as a Public Health Emergency of Intemational Concern on 8th August, 2014, Sincerely, Jane Burgermeister 3 of 104 23/07/2015 13:22,Gmail - Irregularities in WHO's Ebola declaration and vaccine trials https://mail.google.com/mail!2ui~2&ik=a961802388&view=plitg, Ca ities in WHO's Ebola declaration and vaccine trials Jane Burgermeister To: Theoktisti Monahi Finally sent it! See below! Am not sure all the MPs email addresses are up to date - Forwarded message ~~ From: Jane Burgermeister Date: 17 February 2015 at 21:46 Subject: Irregularities in WHO's Ebola deciaration and vaccine trials {Quoted text hideon) attachments formenty-1[1].png 47K /accines_Open_Letter pdf.pdf Haortl email.oxps 2 aseK ‘q2) Hinausschrift BMIG-92400_0049- B_8_2009_20.05.2009_Burgermeister, Jane({).paf 58K lof! il Jane Busyemalater 17 February 2016 at 19:48 23/07/2015 13:29Gmail - Ebola vaccines can be given under the Medical Innovation ....__https://mail.google.com/mail/2ui~2®ik=a961802388&view=plég, £48] Gm I | Jane Burgermeister Ebola vaccines can be given under the Medical Innovation Bill without approval Jane Burgermeis From: Jane Burgermeister Date: 24 February 2015 at 16.31 Subject: Ebola vaccines can be given under the Medical Innovation Bill without approval To: wollastons@parliament.uk, teathers@parliament.uk, James. Kelly.msp@scottish parliament.uk, CMOweb@dh gsi.gov.uk, phso.enquiries@ombudsman org uk, england. contactus@nhs.net, health@unison.co.uk, executive. council@unitetheunion.org, scotland@unitetheunion.org, BMAScotland@bma.org.uk, BMAWales@bma org.uk, BMANorthemlreland@bma.org.uk, simon.danczuk. mp@parliament.uk, siobhain.medonagh mp@parliament uk, thesecretary@toryclubs.co.uk, news@exaronews.net, new.scotland.yard@met.police.uk, office@ westminsterconservatives.co.uk, abboid@parliament.uk, adamsg@parliament.uk, adamsn@parliament.uk, afriyiea@parliament.uk, einsworthb@parliament.uk, aldousp@parliament.uk, alexanderd@parliament.uk, alexandera@parliament.uk, alir@parliament.uk, alleng@parliament uk, amessd@parliament.uk, andersond@parliament.uk, andrews@parliament.uk, arbuthnolj@parliament.uk, austini@parliament.uk, baconr@pariiament. uk, bagshawel@parliament.uk, baileya@partiament.uk, bainw@parliament.uk, baker@parliament uk, bakers@parliament uk, baldryt@parliament.uk, EdBalisMP , banksg@parliament uk, barclays@pariiament uk, barkerg@parliament uk, barronj@parliament uk, barwellg@parliament uk, barclayh@parliament.uk, bebbg@parliament.uk, beckettm@partiament.uk, begga@partiament uk, beitha@parliament.uk, bells@pariiament uk, bellinghamh@parliament.uk, bennh@parliement.uk, bentonj@parliament.uk, benyonr@parliament uk, bercowj@pariament. uk, beresforép@parliament uk, bergeri@pariiament uk, berryj@parliament.uk, Clive Betts , binghama@parliament.uk, binleyb@partiament.uk, birtwhistleg@parliament.uk, blackmanb@parliament.uk, blackman- woodsr@parliament.uk, blackwoodn@pariiament.uk, blearsh@parliament uk, blenkinsopt@parliament.uk, blomfieldp@partiament uk, Rt Hon David Blunkett MP , blunte@parliament uk, bolesn@parliament uk, bonep@parliament.uk, Peter Bottomley , bredleyk@parliament.uk, bradshawb@parliament.uk, blaket@pariiament.uk, braya@parliament uk, brazierj@parliament.uk, bridgena@pariiament.uk, brines@parliament uk, brockenshire|@pariiament.uk, brookea@pariiament.uk, brownn@parliament.uk, brownr@pariiament.uk, browng@parliament uk, brownl@parliament.uk, brownej@partiament.uk, brucem@parliament.uk, brucef@parliament.uk, Karen Buck , bucklandr@parliament.uk, Richard Burden , burleya@parliament uk, burnhama@pariiament uk, burnss@parliament.uk, burnsc@parliament uk, burrowsd@parliament.uk, burstowp@parliament.uk, burtaa@parliament.uk, burtI@parliament.uk, bylesd@parliament.uk, Liam Byrne , cablev@pariiament uk, caimsd@parliament.uk, dakinn@parliament.uk, danczuks@parliament.uk, darlinga@parliament.uk, daveye@parliament uk, davidw@pariament uk, davidsona@parliament.uk, pikel@pariiament uk, daviesp@parliamont.uk, glyndavies8@btintemet.com, davidd@parliament.uk, nick debois@parliament uk, gloria@gloriadmp.org, denheamj@parliament uk, dinenagec@parliament uk, djanoglyj@parliament uk, dobbinj@parliament uk, donsonf@parliament uk, dochertyt@parliament.uk, doddsn@parliament.uk, dohertyp@pariament.uk, donaldsonjm@parliament.uk, Brian Donohoe , doranf@parliament.uk, dorrells@parliament.uk, dorriesn@pariiament.uk, dowdj@parliament.uk, doyleg@pariiament.uk, draxr@parliament uk, dromeyj@parliament.uk, duddridgej@pariament.uk, dugherm@parliament.uk, duncana@parliament.uk, dunnep@parliament.uk, durkanm@parliament.uk, ‘eaglem@parliament.uk, eaglea@parliament.uk, edwards|@pariiament.uk, effordc@parliament.uk, ellioti@parliament uk, eliism@partiament.uk, ellisonj@parliament uk, ellmanm@parliament.uk, ellwoodt@pariiament uk, elphickec@parliament.uk, engeln@partiament.uk, estersonb@parliament.uk, eustice3g@parliament.uk, evansc@parliament uk, evansg@parliament uk, evans|@parliament.uk, David Evennett , Michael Fabricant , fallonm@parliament.uk, farrellyp@parliament uk, farront@parliament.uk, Lynne Featherstone , Frank Field , fieldm@parliament uk, fitzpatrickj@parliament.uk, flellor@parliament.uk, flinte@parliament uk, flynnp@parliament.uk, fosterd@parliament uk, fovarquey@pariiament.uk, foxi@pariament uk, francish@pariiament uk, fullbrook|@parliament.uk, galer@pariiament.uk, Mike Gapes , gardinerb@parliament.uk, garniere@parliament.uk, garnierm@parliament.uk, gauked@partiament.uk, gobbn@parliament uk, gilberts@parliament uk, gildernew@parliament.uk, gilanc@parliament.uk, gilmores@parliament.uk, glassp@parliament.uk, glenj@pariament uk, glindonm@parliament.uk, godsifir@parliament uk, Lota 23/07/2015 13:26